Home > Healthcare > Pharmaceuticals > Finished Drug Form > Lipid Regulators Market

Lipid Regulators Market Share

  • Report ID: GMI8442
  • Published Date: Mar 2024
  • Report Format: PDF

Lipid Regulators Market Share

The lipid regulators industry is dynamic and multifaceted, characterized by several key players and a diverse range of lipid regulators. Competition in the global market is influenced by factors such as drug efficacy, safety, pricing, marketing strategies, and regulatory approvals. Companies strive to differentiate their products through clinical advancements, novel mechanisms of action, and strategic partnerships to gain market share and maintain a competitive edge in this dynamic and rapidly evolving market.
 

Lipid Regulators Market Companies

Prominent players operating in the lipid regulators industry include:

  • AbbVie Inc
  • Amgen Inc.
  • AstraZeneca plc
  • Bristol-Myers Squibb
  • Dr. Reddy's Laboratories Ltd.
  • Merck & Co.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Teva Pharmaceuticals
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market size for lipid regulators was valued at USD 32.4 billion in 2023 and is set to register 3.8% CAGR from 2024 to 2032, driven by the rising prevalence of dyslipidemia and cardiovascular disease, advancements in drug development, and growing awareness of the importance of lipid management in reducing cardiovascular risk.

The statins segment accounted for 60.1% market share in 2023 and is anticipated to record 4.1% CAGR from 2024 to 2032 as they are recommended as first-line therapy in treatment guidelines issued by organizations such as the American College of Cardiology (ACC).

North America market for lipid regulators accounted for USD 13.6 billion in 2023 and is projected to reach USD 18.1 billion by 2032, as the region faces a significant burden of cardiovascular disease.

AbbVie Inc, Amgen Inc., AstraZeneca plc, Bristol-Myers Squibb, Dr. Reddy's Laboratories Ltd., Merck & Co., Novartis AG, Pfizer, Inc., Sanofi, and Teva Pharmaceuticals.

Lipid Regulators Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 355
  • Countries covered: 19
  • Pages: 203
 Download Free Sample